DeepMed Research

Therapeutics, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1997-01-01

Employees: 51

Market Cap: -

Website: http://www.therapeuticsinc.com

Clinical Trials

Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

Phase 1

Completed

Conditions: Tinea Cruris
Tinea Pedis

Interventions: Drug: Naftin (naftifine hydrochloride) Cream
Drug: UHE-103 Cream

First Posted Date: 2022-05-05

Last Posted Date: 2024-04-10

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 42

Registration Number: NCT05363449

Locations: 🇺🇸
Site #4, Houston, Texas, United States
🇺🇸
Site #1, San Diego, California, United States
🇺🇸
Site #5, Thousand Oaks, California, United States

and more 2 locations

A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis

Phase 2

Completed

Conditions: Scalp Psoriasis

Interventions: Drug: UHE-105
Drug: Vehicle

First Posted Date: 2020-01-28

Last Posted Date: 2020-07-09

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 22

Registration Number: NCT04243486

Locations: 🇺🇸
01, San Diego, California, United States
🇺🇸
02, High Point, North Carolina, United States

A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis

Phase 2

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: 188-0551 Spray
Drug: RLD

First Posted Date: 2019-09-06

Last Posted Date: 2021-05-10

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 55

Registration Number: NCT04080206

Locations: 🇺🇸
TI Site #11, Miami, Florida, United States
🇺🇦
TI Site #23, Lviv, Ukraine
🇬🇪
TI Site #31, Batumi, Georgia

and more 5 locations

A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis

Phase 2

Completed

Conditions: Tinea Pedis

Interventions: Drug: UHE-103A2B cream
Drug: UHE-103A1 cream
Drug: UHE-103A2 cream
Drug: UHE-103B cream
Drug: UHE-103A1B cream

First Posted Date: 2019-04-01

Last Posted Date: 2021-10-28

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 240

Registration Number: NCT03897257

Locations: 🇵🇷
Site 08, Cidra, Puerto Rico
🇺🇸
Site 02, Houston, Texas, United States
🇺🇸
Site 12, Melbourne, Florida, United States

and more 9 locations

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

Phase 3

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: 188-0551 Spray
Drug: Vehicle Spray

First Posted Date: 2018-11-29

Last Posted Date: 2020-02-25

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 206

Registration Number: NCT03759197

Locations: 🇺🇸
Site 09, Fountain Valley, California, United States
🇺🇸
Site 06, Fort Smith, Arkansas, United States
🇺🇸
Site 07, Fremont, California, United States

and more 9 locations

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

Phase 3

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: 188-0551 Spray
Drug: Vehicle Spray

First Posted Date: 2018-11-06

Last Posted Date: 2020-02-25

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 217

Registration Number: NCT03731052

Locations: 🇺🇸
Site 08, San Antonio, Texas, United States
🇺🇸
Site 15, Austin, Texas, United States
🇺🇸
Site 04, Los Angeles, California, United States

and more 11 locations

A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris

Phase 2

Completed

Conditions: Acne Vulgaris

Interventions: Other: Vehicle Cream
Drug: UHE-101 Cream

First Posted Date: 2017-10-11

Last Posted Date: 2019-05-24

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 52

Registration Number: NCT03307577

Locations: 🇺🇸
Site 02, San Diego, California, United States

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

Phase 2

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: Vehicle Solution
Drug: 188-0551 Solution

First Posted Date: 2017-02-28

Last Posted Date: 2018-08-10

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 89

Registration Number: NCT03065556

Locations: 🇺🇸
Site 01, Arlington Heights, Illinois, United States

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

Phase 3

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: 122-0551 Foam
Drug: Vehicle Foam

First Posted Date: 2016-04-19

Last Posted Date: 2018-11-14

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 409

Registration Number: NCT02742441

Locations: 🇺🇸
Site 12, Pinellas Park, Florida, United States
🇺🇸
Site 01, Hot Springs, Arkansas, United States
🇺🇸
Site 03, Spokane, Washington, United States

and more 18 locations

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)

Phase 3

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: 122-0551 Foam
Drug: Vehicle Foam

First Posted Date: 2015-02-23

Last Posted Date: 2018-11-26

Lead Sponsor: Therapeutics, Inc.

Target Recruit Count: 151

Registration Number: NCT02368210

Locations: 🇺🇸
International Dermatology Research, Inc., Miami, Florida, United States
🇺🇸
Dermatology Associates of Knoxville, Knoxville, Tennessee, United States
🇺🇸
Academic Dermatology Associates, Albuquerque, New Mexico, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy